Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

BACKGROUND: Adalimumab has been used in patients with moderately to severely active rheumatoid arthritis (RA) for over 10 years and has a well-established safety profile across multiple indications. OBJECTIVE: To update adverse events (AEs) of special interest from global adalimumab clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R, Landewé, Robert, Genovese, Mark C, Friedman, Alan W, Pfeifer, Nathan D, Varothai, Nupun A, Lacerda, Ana P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284339/
https://www.ncbi.nlm.nih.gov/pubmed/27338778
http://dx.doi.org/10.1136/annrheumdis-2016-209322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284339/
https://www.ncbi.nlm.nih.gov/pubmed/27338778
http://dx.doi.org/10.1136/annrheumdis-2016-209322

Ejemplares similares